Eledon Pharmaceuticals Inc. diskutieren
Eledon Pharmaceuticals Inc.
WKN: A2QL00 / Symbol: ELDN / Name: Eledon Pharma / Aktie / Pharmazeutika / Micro Cap /
1,32 €
2,33 %
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $10.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its price target lowered by analysts at HC Wainwright from $25.00 to $13.00. They now have a "buy" rating on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its price target raised by analysts at HC Wainwright from $13.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $9.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $9.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Eledon Pharmaceuticals (NASDAQ:ELDN) had its price target lowered by analysts at Guggenheim from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for ELDN provided by MarketBeat
Neueste Beiträge
LADENBURG_THALM_SH_S in Tanger Factory Outlet diskutieren